Reduction of signal suppression effects in ESI-MS using a nanosplitting device

被引:145
作者
Gangl, ET
Annan, M
Spooner, N
Vouros, P [1 ]
机构
[1] Northeastern Univ, Barnett Inst, Boston, MA 02115 USA
[2] Northeastern Univ, Dept Chem, Boston, MA 02115 USA
[3] GlaxoSmithKline Pharmaceut, King Of Prussia, PA 19406 USA
关键词
D O I
10.1021/ac010501i
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Electrospray ionization mass spectrometry is a valuable tool in the identification and quantification of drug metabolites in biological fluids. However, there are many instances where matrix components present in these fluids interfere with analyte detection and prevent the acquisition of accurate or complete results. In some instances, the matrix can suppress ionization to such an extent that analytes are completely undetectable by MS. In this work, we investigate how ionization and ion-transfer efficiencies are affected by drastically reducing the flow into the MS. A postcolumn concentric flow-splitting device was constructed to allow the measurement of analyte signal and ionization suppression across a range of flow rates (0.1-200 muL/min). Using this device, the effects of flow rate on signal intensity and ionization suppression were measured in analytical experiments that included flow injection analysis MS, postcolumn addition LC-MS, and on-line LC-MS analysis of metabolites generated from rat liver microsomes. The device used to deliver 0.1 muL/min flows is referred to as a nanosplitter because it achieved high split ratios (2000: 1), producing flow rates comparable to those observed in nanoelectrospray. The nanosplitter maintained chromatographic integrity with high fidelity and allowed the direct comparison of analyte signal across a range of flow rates (0.1-200 muL/min). A significant improvement in concentration and mass sensitivity as well as a reduction in signal suppression is observed when the performance at 200 versus 0.1 muL/min flow rate is compared. Using this specially designed concentric splitting device, the advantages of ultralow flow ESI were easily exploited for applications employing large bore chromatography.
引用
收藏
页码:5635 / 5644
页数:10
相关论文
共 32 条
  • [1] Analysis of terfenadine in human plasma using microbore high-performance liquid chromatography electrospray ionisation mass spectrometry
    Adams, DA
    Murray, S
    Clifford, CP
    Rendell, NB
    Davies, DS
    Taylor, GW
    [J]. JOURNAL OF CHROMATOGRAPHY B, 1997, 693 (02): : 345 - 351
  • [2] High sensitivity analysis of neutral underivatized oligosaccharides by nanoelectrospray mass spectrometry
    Bahr, U
    Pfenninger, A
    Karas, M
    Stahl, B
    [J]. ANALYTICAL CHEMISTRY, 1997, 69 (22) : 4530 - 4535
  • [3] Bonfiglio R, 1999, RAPID COMMUN MASS SP, V13, P1175, DOI 10.1002/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.3.CO
  • [4] 2-S
  • [5] Rapid analysis of conjugated bile acids in plasma using electrospray tandem mass spectrometry: Application for selective screening of peroxisomal disorders
    Bootsma, AH
    Overmars, H
    van Rooij, A
    van Lint, AEM
    Wanders, RJA
    van Gennip, AH
    Vreken, P
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (03) : 307 - 310
  • [6] Burlingame AL, 1998, ANAL CHEM, V70, p647R
  • [7] Quantitative electrospray LC-MS and LC-MS/MS in biomedicine
    Carrascal, M
    Schneider, K
    Calaf, RE
    van Leeuwen, S
    Canosa, D
    Gelpí, E
    Abian, J
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 17 (6-7) : 1129 - 1138
  • [8] Effects of salt concentration on analyte response using electrospray ionization mass spectrometry
    Constantopoulos, TL
    Jackson, GS
    Enke, CG
    [J]. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 1999, 10 (07) : 625 - 634
  • [9] INTERFACING MICROBORE AND CAPILLARY LIQUID-CHROMATOGRAPHY TO CONTINUOUS-FLOW FAST-ATOM-BOMBARDMENT MASS-SPECTROMETRY FOR THE ANALYSIS OF GLYCOPEPTIDES
    COUTANT, JE
    CHEN, TM
    ACKERMANN, BL
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 529 (02): : 265 - 275
  • [10] Rapid determination of the anti-cancer drug chlorambucil (Leukeran™) and its phenyl acetic acid mustard metabolite in human serum and plasma by automated solid-phase extraction and liquid chromatography-tandem mass spectrometry
    Davies, ID
    Allanson, JP
    Causon, RC
    [J]. JOURNAL OF CHROMATOGRAPHY B, 1999, 732 (01): : 173 - 184